Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: Results from the SHIFT study

European Heart Journal

Volumn 32, Issue 19, 2011, Pages 2395-2404

  Ekman, Inger ^a,b   Chassany, Olivier ^c,d   Komajda, Michel ^e,f   Bhm, Michael ^g   Borer, Jeffrey S ^h   Ford, Ian ⁱ   Tavazzi, Luigi ^j   Swedberg, Karl ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g SAARLAND UNIVERSITY   (Germany)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j MARIA CECILIA HOSPITAL   (Italy)

more..

Author keywords

Health related quality of life; Heart failure; Heart rate; Ivabradine; Prognosis

Indexed keywords

IVABRADINE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART RATE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BENZAZEPINES; CAUSE OF DEATH; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 80054070561     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr343     Document Type: Article

References (20)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
2. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87: 235-241. (Pubitemid 34177677)
3. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 2004;110:546-551. (Pubitemid 39031171)
4. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996;334:835-840.
5. Russell SD, McNeer FR, Higginbotham MB. Exertional dyspnea in heart failure: a symptom unrelated to pulmonary function at rest or during exercise. Duke University Clinical Cardiology Studies (DUCCS) Exercise Group. Am Heart J 1998; 135:398-405. (Pubitemid 28125674)
6. Shah MR, Hasselblad V, Stinnett SS, Kramer JM, Grossman S, Gheorghiade M, Adams KF Jr., Swedberg K, Califf RM, O'Connor CM. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 2002;4:297-304. (Pubitemid 35190354)
7. Dobre D, van Jaarsveld CH, de Jongste MJ, Haaijer Ruskamp FM, Ranchor AV. The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 2007;16:152-159. (Pubitemid 46291167)
8. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:875-885.
9. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Tavazzi L. Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT). Eur J Heart Fail 2010;12:75-81.
10. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-1255. (Pubitemid 30206900)
11. Stanek EJ,Oates MB, McGhanWF, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms vs. survival. J Card Fail 2000;6:225-232.
12. Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age-and gender-matched community controls. J Card Fail 2009;15:17-23.
13. Ekman I, Kjork E, Andersson B. Self-assessed symptoms in chronic heart failure-important information for clinical management. Eur J Heart Fail 2007;9:424-428. (Pubitemid 46441979)
14. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail 2005;11:288-292. (Pubitemid 40616899)
15. Zuluaga MC, Guallar-Castillon P, Lopez-Garcia E, Banegas JR, Conde-Herrera M, Olcoz-Chiva M, Rodriguez-Pascual C, Rodriguez-Artalejo F. Generic and diseasespecific quality of life as a predictor of long-term mortality in heart failure. Eur J Heart Fail 2010;12:1372-1378.
16. Evaluation of Medicines for human use. 2010. Accessed at http://www.emea.eu. int/pdfs/human/ewp/298603en.pdf.
17. Services USDoHaH, Food and Drug Administration. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. Accessed at http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
18. Flynn KE, Lin L, Ellis SJ, Russell SD, Spertus JA, Whellan DJ, Pina IL, Fine LJ, Schulman KA, Weinfurt KP. Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. Am Heart J 2009;158:S64-S71.
19. Pettersen KI, Reikvam A, Rollag A, Stavem K. Reliability and validity of the Kansas City cardiomyopathy questionnaire in patients with previous myocardial infarction. Eur J Heart Fail 2005;7:235-242. (Pubitemid 40215619)
20. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 2006;47:752-756. (Pubitemid 43243096)